Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months
Written by Thomas Niel for The Motley Fool -> Boston Scientific's shares have fallen over 50% year to date as the medtech company continues to walk back full-year 2026 guidance. Sell-side analysts โฆ
Nasdaq News โ 12 June 2026
Text:
15
0
0
Boston Scientific's shares have fallen over 50% year to date as the medtech company continues to walk back full-year 2026 guidance. Boston Scientific
Read Full Story at Nasdaq News โ Sources

